Novel investigational vascular endothelial growth factor (VEGF) receptor antagonists for psoriasis
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Novel investigational vascular endothelial growth factor (VEGF) receptor antagonists for psoriasis
Authors
Keywords
-
Journal
EXPERT OPINION ON INVESTIGATIONAL DRUGS
Volume 25, Issue 4, Pages 455-462
Publisher
Informa Healthcare
Online
2016-02-11
DOI
10.1517/13543784.2016.1153064
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Anti-TNF-α monoclonal antibody reverses psoriasis through dual inhibition of inflammation and angiogenesis
- (2015) Yu Liu et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Anti-psoriatic effects of Honokiol through the inhibition of NF-κB and VEGFR-2 in animal model of K14-VEGF transgenic mouse
- (2015) Jiaolin Wen et al. JOURNAL OF PHARMACOLOGICAL SCIENCES
- Psoriasis and metabolic syndrome: A systematic review and meta-analysis of observational studies
- (2013) April W. Armstrong et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Antiangiogenic agents in the management of non-small cell lung cancer
- (2012) Charu Aggarwal et al. CANCER BIOLOGY & THERAPY
- Anti-VEGF Strategies – from Antibodies to Tyrosine Kinase Inhibitors: Background and Clinical Development in Human Cancer
- (2012) Grzegorz Korpanty et al. CURRENT PHARMACEUTICAL DESIGN
- Aflibercept
- (2012) Michael W. Stewart et al. NATURE REVIEWS DRUG DISCOVERY
- Neovascular Age-Related Macular Degeneration
- (2012) Daniele Veritti et al. OPHTHALMOLOGICA
- Pharmacogenetics of antiangiogenic and antineovascular therapies of age-related macular degeneration
- (2012) Elisa Agosta et al. PHARMACOGENOMICS
- Vascular Endothelial Growth Factor (VEGF), VEGF Receptors and Their Inhibitors for Antiangiogenic Tumor Therapy
- (2011) Satoru Takahashi BIOLOGICAL & PHARMACEUTICAL BULLETIN
- Aflibercept (VEGF Trap) in Inoperable Stage III or Stage IV Melanoma of Cutaneous or Uveal Origin
- (2011) A. A. Tarhini et al. CLINICAL CANCER RESEARCH
- Double Anti-angiogenic and Anti-inflammatory Protein Valpha Targeting VEGF-A and TNF-α in Retinopathy and Psoriasis
- (2011) Keehoon Jung et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Dimethylfumarate Inhibits Angiogenesis In Vitro and In Vivo: A Possible Role for Its Antipsoriatic Effect?
- (2011) Melissa García-Caballero et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Suppression of VEGFR2 Expression in Human Endothelial Cells by Dimethylfumarate Treatment: Evidence for Anti-Angiogenic Action
- (2011) Markus Meissner et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Improvement of Psoriasis During Sunitinib Therapy for Renal Cell Carcinoma
- (2010) Sujata Narayanan et al. AMERICAN JOURNAL OF THE MEDICAL SCIENCES
- FDA Drug Approval Summary: Bevacizumab plus Interferon for Advanced Renal Cell Carcinoma
- (2010) J. Summers et al. ONCOLOGIST
- Cardiovascular toxicity following sunitinib therapy in metastatic renal cell carcinoma: a multicenter analysis
- (2009) G. Di Lorenzo et al. ANNALS OF ONCOLOGY
- Vandetanib (ZD6474), a Dual Inhibitor of Vascular Endothelial Growth Factor Receptor (VEGFR) and Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinases: Current Status and Future Directions
- (2009) A. Morabito et al. ONCOLOGIST
- Systemic anti-VEGF treatment strongly reduces skin inflammation in a mouse model of psoriasis
- (2009) Helia B. Schonthaler et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Inhibition of Chronic and Acute Skin Inflammation by Treatment with a Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitor
- (2008) Cornelia Halin et al. AMERICAN JOURNAL OF PATHOLOGY
- Cardiotoxicity associated with the cancer therapeutic agent sunitinib malate
- (2008) M. L. Telli et al. ANNALS OF ONCOLOGY
- Heart failure associated with sunitinib malate
- (2008) Aarif Y. Khakoo et al. CANCER
- Complete remission of psoriasis following bevacizumab therapy for colon cancer
- (2008) A. Akman et al. CLINICAL AND EXPERIMENTAL DERMATOLOGY
- Cardiac Toxicity of Sunitinib and Sorafenib in Patients With Metastatic Renal Cell Carcinoma
- (2008) Manuela Schmidinger et al. JOURNAL OF CLINICAL ONCOLOGY
- Discrepant levels of vascular endothelial growth factor in psoriasis patients treated with PUVA, Re-PUVA and narrow-band UVB
- (2008) Ayse Akman et al. PHOTODERMATOLOGY PHOTOIMMUNOLOGY & PHOTOMEDICINE
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started